Ani Pharmaceuticals (ANIP) Current Deferred Revenue (2018 - 2022)
Ani Pharmaceuticals (ANIP) reported Current Deferred Revenue of $116,000 for Q1 2022, up 16.0% from $100,000 a year earlier and up 16.0% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Current Deferred Revenue (2018 - 2022) Analysis & Trends
At the end of FY2021, Ani Pharmaceuticals posted Current Deferred Revenue of $100,000, unchanged from FY2020.
- Current Deferred Revenue has a three-year compound annual growth rate of -48.0% (FY2018 to FY2021).
- By year, Current Deferred Revenue came in at $100,000 in FY2020 (-80.0%), $500,000 in FY2019 (-29.7%) and $711,000 in FY2018.
- The Q1 2022 figure ranks as the highest quarterly Current Deferred Revenue since Q2 2020.
- Year over year, Current Deferred Revenue gained in 1 of the last eight quarters, with an average decline of 39.8%.
- The high point for year-over-year Current Deferred Revenue in five years was Q1 2022 (growth of 16.0%); the low point was Q4 2020 (a decline of 80.0%).
- Per Business Quant data, the three quarters before Q1 2022 came in at $100,000 (Q4 2021), $100,000 (Q3 2021) and $100,000 (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ani Pharmaceuticals | 1.73 Bn | 513.34 Mn | 165.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 112,000.00 |
| Jun 30, 2020 | 125,000.00 |
| Mar 31, 2020 | 318,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 496,000.00 |
| Jun 30, 2019 | 558,000.00 |
| Mar 31, 2019 | 624,000.00 |
| Dec 31, 2018 | 711,000.00 |
| Sep 30, 2018 | 735,000.00 |
API Access
Ani Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();